معرفی
Liwen Ren is a Research Fellow in Pharmacology at the Yale School of Medicine, Yale University. Their research focuses on cancer biology and drug development, particularly in glioblastoma, lung carcinoma, and pancreatic cancer. Key interests include tumor metabolism, ferroptosis regulation, and immune mechanisms in cancer progression. Ren has contributed to studies on therapeutic targets such as MELK kinase, Skp2 inhibitors, and apolipoprotein C1 (APOC1) biomarkers.
Publications highlight advancements in drug design (e.g., S670 derivative for glioblastoma), epigenetic therapies, and combinatorial treatments for metabolic diseases. Collaborative work spans molecular biology, pharmacology, and computational drug screening.
No scientific awards are explicitly mentioned in the provided texts. Current roles involve advancing preclinical drug candidates and investigating cellular pathways in oncogenesis. No listed advisees or grants are noted in the current profile.
